The METOP Study: Further Evidence for the Use of Subcutaneous Methotrexate in Psoriasis
- PMID: 28583269
- DOI: 10.1016/j.ad.2017.04.007
The METOP Study: Further Evidence for the Use of Subcutaneous Methotrexate in Psoriasis
Keywords: METOP; Methotrexate; Metotrexato; Psoriasis; Subcutaneous; Subcutáneo.
Similar articles
-
Effectiveness of methotrexate in moderate to severe psoriasis patients: real-world registry data from the Swiss Dermatology Network for Targeted Therapies (SDNTT).Arch Dermatol Res. 2019 Dec;311(10):753-760. doi: 10.1007/s00403-019-01945-6. Epub 2019 Aug 8. Arch Dermatol Res. 2019. PMID: 31396693
-
The use of self-administered subcutaneous methotrexate for the treatment of psoriasis.J Drugs Dermatol. 2014 Aug;13(8):929-31. J Drugs Dermatol. 2014. PMID: 25116970
-
Psoriasis: the new and the old.J Drugs Dermatol. 2014 Aug;13(8):894. J Drugs Dermatol. 2014. PMID: 25116962 No abstract available.
-
Methotrexate: new therapeutic approaches.Actas Dermosifiliogr. 2014 Jul-Aug;105(6):583-9. doi: 10.1016/j.ad.2012.11.017. Epub 2013 Feb 22. Actas Dermosifiliogr. 2014. PMID: 23434058 Review. English, Spanish.
-
Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?Am J Clin Dermatol. 2005;6(6):357-63. doi: 10.2165/00128071-200506060-00003. Am J Clin Dermatol. 2005. PMID: 16343024 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical